Abstract

Parkinson’s disease (PD) is the second most common neurodegenerative disease. Accurate PD diagnosis is crucial for effective treatment and prognosis but can be challenging, especially at early disease stages. This study aimed to develop and evaluate an explainable deep learning model for PD classification from multimodal neuroimaging data. The model was trained using one of the largest collections of T1-weighted and diffusion-tensor magnetic resonance imaging (MRI) datasets. A total of 1264 datasets from eight different studies were collected, including 611 PD patients and 653 healthy controls (HC). These datasets were pre-processed and non-linearly registered to the MNI PD25 atlas. Six imaging maps describing the macro- and micro-structural integrity of brain tissues complemented with age and sex parameters were used to train a convolutional neural network (CNN) to classify PD/HC subjects. Explainability of the model’s decision-making was achieved using SmoothGrad saliency maps, highlighting important brain regions. The CNN was trained using a 75%/10%/15% train/validation/test split stratified by diagnosis, sex, age, and study, achieving a ROC-AUC of 0.89, accuracy of 80.8%, specificity of 82.4%, and sensitivity of 79.1% on the test set. Saliency maps revealed that diffusion tensor imaging data, especially fractional anisotropy, was more important for the classification than T1-weighted data, highlighting subcortical regions such as the brainstem, thalamus, amygdala, hippocampus, and cortical areas. The proposed model, trained on a large multimodal MRI database, can classify PD patients and HC subjects with high accuracy and clinically reasonable explanations, suggesting that micro-structural brain changes play an essential role in the disease course.

Details

Title
Exploiting macro- and micro-structural brain changes for improved Parkinson’s disease classification from MRI data
Author
Camacho, Milton 1   VIAFID ORCID Logo  ; Wilms, Matthias 2   VIAFID ORCID Logo  ; Almgren, Hannes 3 ; Amador, Kimberly 1   VIAFID ORCID Logo  ; Camicioli, Richard 4 ; Ismail, Zahinoor 5 ; Monchi, Oury 6 ; Forkert, Nils D. 7   VIAFID ORCID Logo 

 University of Calgary, Biomedical Engineering Graduate Program, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Radiology, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 University of Calgary, Department of Radiology, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Alberta Children’s Hospital Research Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Pediatrics and Community Health Sciences, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Hotchkiss Brain Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 University of Calgary, Hotchkiss Brain Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Clinical Neurosciences, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 University of Alberta, Neuroscience and Mental Health Institute and Department of Medicine (Neurology), Edmonton, Canada (GRID:grid.17089.37) 
 University of Calgary, Hotchkiss Brain Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Clinical Neurosciences, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Psychiatry, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Exeter, College of Medicine and Health, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024) 
 University of Calgary, Hotchkiss Brain Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Clinical Neurosciences, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); Université de Montréal, Department of Radiology, Radio-oncology and Nuclear Medicine, Montréal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136); Institut Universitaire de Gériatrie de Montréal, Centre de Recherche, Montréal, Canada (GRID:grid.294071.9) (ISNI:0000 0000 9199 9374) 
 University of Calgary, Department of Radiology, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Alberta Children’s Hospital Research Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Pediatrics and Community Health Sciences, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Hotchkiss Brain Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Clinical Neurosciences, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
Pages
43
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
23738057
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2931866093
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.